|
|
|
|
|
|
||
|
|
||||
|
|
||||
|
||||
Medical Neuro-Oncology |
Kaiser Permanente Medical Group, Department of Neurology, Baldwin Park, CA 91706 (M.C.C.); Department of Nursing, University of California at San Diego, San Diego, CA 92103 (P.A.K.); and University of Massachusetts, School of Public Health and Health Sciences, Amherst, MA 01003 (M.J.G.)
1 Address correspondence and reprint requests to Marc C. Chamberlain, Kaiser Permanente Medical Group, Department of Neurology, 1011 Baldwin Park Blvd., Baldwin Park, CA 91706.
Abstract
Leptomeningeal metastases (LMs) are common metastatic complications, occurring in at least 5% of patients with disseminated cancer. Cerebrospinal `uid (CSF) cytology remains the standard for diagnosis and assessment of treatment response, but may be inadequate. Our objective was to compare ventricular and lumbar CSF cytology in patients who had cytologically proven LM and were receiving intra-CSF chemotherapy. Sixty patients with LM, positive lumbar CSF cytology documented at diagnosis, limited extent of CNS disease, and no evidence of CSF `ow obstruction were treated with a variety of intra-CSF chemotherapies. All patients underwent a single simultaneous ventricular and lumbar CSF sampling (mean volume of CSF per site examined, 10 ml) to assess response to therapy at either 1 or 2 months after treatment initiation. Ventricular CSF cytology was positive in 44 patients (73%), 35 of whom were also positive by lumbar CSF cytology. Lumbar CSF cytology was positive in 45 patients (75%), of which 35 were also positive by ventricular CSF cytology. Samples were negative at both ventricular and lumbar sites in 6 patients (10%). Paired CSF cytologies were discordant in 19 (32%) patients. The lumbar cytology was negative in 9, whereas the ventricular cytology was positive (lumbar false-negative rate of 17%); the ventricular cytology was negative in 10, whereas the lumbar cytology was positive (ventricular false-negative rate of 20%). In the presence of spinal signs or symptoms of LM, the lumbar CSF cytology was more likely to be positive than was the ventricular (odds ratio = 2.86; 95% confidence interval, 0.86-9.56). Conversely, in the presence of cranial signs or symptoms, the ventricular CSF cytology was more likely to be positive than was the lumbar (odds ratio = 2.71; 95% confidence interval, 0.76-9.71). In this cohort of patients, whose LM was documented initially by positive lumbar CSF cytology, ventricular and lumbar CSF samples obtained during treatment had similar false-negative rates, depending on the site of clinical or radiologic disease. This suggests that both lumbar and ventricular sites must be sampled when assessing treatment response. If clinical or radiographic disease is present only at 1 site, then CSF from that site is more likely to be positive than is CSF obtained from the more distant site.
References
Bigner, S.H. (1998) Cerebrospinal `uid: Cytologic interpretation. In Bigner, D.D., McLendon, R.E., and Brunner, J.M. (Eds.), Russell and Rubinstein's Pathology of Tumors of the Nervous System. Sixth edition. London: Arnold. pp.681 -702.
Chamberlain, M.C. (1998a) Leptomeningeal metastases: A review of evaluation and treatment. J. Neurooncol. 37,271 -284.[CrossRef][Medline]
Chamberlain, M.C. (1998b) Radioisotope CSF `ow studies in leptomeningeal metastases. J. Neurooncol. 38,135 -140.[CrossRef][Medline]
Chamberlain, M.C., and Kormanik, P.A. (1997)
Prognostic significance of coexistent bulky metastatic central nervous system
disease in patients with leptomeningeal metastases. Arch.
Neurol. 54,1364
-1368.
Freilich, R.J., Krol, G., and DeAngelis, L.M. (1995) Neuroimaging and cerebrospinal `uid cytology in the diagnosis of leptomeningeal metastasis. Ann. Neurol. 38, 51-57.[CrossRef][Web of Science][Medline]
Gajjar, A., Fouladi, M., Walter, A.W., Thompson, S.J., Reardon,
D.A., Merchant, T.E., Jenkins, J.J., Liu, A., Boyett, J.M., Kun, L.E., and
Heideman, R.L. (1999) Comparison of lumbar and shunt
cerebrospinal `uid specimens for cytologic detection of leptomeningeal disease
in pediatric patients with brain tumors. J. Clin.
Oncol. 17,1825
-1828.
Glantz, M.J., Cole, B.F., Glantz L.K., Cobb, J., Mills, P., Lekos, A., Walters, B.C., and Recht, L.D. (1998) Cerebrospinal `uid cytology in patients with cancer: Minimizing false-negative results. Cancer 82,733 -739.[CrossRef][Web of Science][Medline]
Glantz, M.J., LaFollette, S., Jaeckle, K.A., Shapiro, W., Swinnen,
L., Rozental, J.R., Phuphanich, S., Rogers, L.R., Gutheil, J.C., Batchelor,
T., Lyter, D., Chamberlain, M., Maris, B.L., Schiffer, C., Bashir, R., Thomas,
D., Cowens, W., and Howell, S.B. (1999) Randomized trial of a
slow-release versus a standard formulation of cytarabine for the treatment of
lymphomatous meningitis. J. Clin. Oncol.
17,3110
-3116.
Glass, J.P., Melamed, M., Chernik, N.L., and Posner, J.B.
(1979) Malignant cells in cerebrospinal (CSF): The meaning of a
positive CSF cytology. Neurology
29,1369
-1375.
Russack, V., Kim, S., and Chamberlain, M.C. (1993) Quantitative cerebrospinal `uid cytology in patients receiving intracavitary chemotherapy. Ann. Neurol. 34,108 -112.[CrossRef][Web of Science][Medline]
Rogers, L.R., Duchesneau, P.M., Nunez, C., Fishleder, A.J., Weick,
J.K., Bauer, L.J., and Boyett, J.M. (1992) Comparison of
cisternal and lumbar CSF examination in leptomeningeal metastasis.
Neurology 42,1239
-1241.
CiteULike 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  M. C. Chamberlain Neoplastic Meningitis Oncologist, September 1, 2008; 13(9): 967 - 977. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. Abrey, T. T. Batchelor, A. J.M. Ferreri, M. Gospodarowicz, E. J. Pulczynski, E. Zucca, J. R. Smith, A. Korfel, C. Soussain, L. M. DeAngelis, et al. Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS Lymphoma J. Clin. Oncol., August 1, 2005; 23(22): 5034 - 5043. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Chamberlain Neoplastic Meningitis J. Clin. Oncol., May 20, 2005; 23(15): 3605 - 3613. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
